Tarbox Family Office’s Myriad Genetics MYGN Stock Holding History

Tarbox Family Office’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-87	Closed	-$2K	–	669
2022 Q1	$2K	Hold	87	–	–	﹤0.01%	828
2021 Q4	$2K	Hold	87	–	–	﹤0.01%	902
2021 Q3	$3K	Hold	87	–	–	﹤0.01%	817
2021 Q2	$3K	Hold	87	–	–	﹤0.01%	828
2021 Q1	$3K	Hold	87	–	–	﹤0.01%	774
2020 Q4	$2K	Hold	87	–	–	﹤0.01%	861
2020 Q3	$1K	Buy	+87	New	+$1.1K	﹤0.01%	1015
2020 Q1	–	Sell	-79	Closed	-$2K	–	1244
2019 Q4	$2K	Hold	79	–	–	﹤0.01%	818
2019 Q3	$2K	Hold	79	–	–	﹤0.01%	760
2019 Q2	$2K	Buy	+79	New	+$2.23K	﹤0.01%	761

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tarbox Family Office's MYGN Position: Q2 2022 in Review

Tarbox Family Office sold out of Myriad Genetics (MYGN) in Q2 2022, closing a stake of 87 shares — an estimated $2K sold.

Tarbox Family Office first reported a position in MYGN in Q2 2019 and held it in 10 quarters. The position peaked at $3K in Q3 2021. 198 funds tracked by Wall St. Rank hold MYGN as of Q2 2022.

Tarbox Family Office reported no remaining Myriad Genetics position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 87 Myriad Genetics shares in Q2 2022, an estimated $2K.
Tarbox Family Office first reported a position in Myriad Genetics in Q2 2019 and held it in 10 quarters.
Tarbox Family Office's Myriad Genetics position peaked at $3K in Q3 2021.
198 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.